Diverse bacteria promote macrophage foam cell formation via Toll-like receptor-dependent lipid body biosynthesis

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 2, 2012, Pages 137-148

  Nicolaou, Giovanna ^a   Goodall, Alison H ^a   Erridge, Clett ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Bacteria; Cholesterol; Foam cell; Lipid body; Toll like receptor

Indexed keywords

CHOLESTEROL ESTER; FATTY ACID SYNTHASE; LIPOPROTEIN; POLYINOSINIC ACID; POLYMYXIN B; RESATORVID; STEAROYL COENZYME A; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9;

ACINETOBACTER BAUMANNII; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOSYNTHESIS; BREVUNDIMONAS DIMINUTA; ESCHERICHIA COLI; FOAM CELL; FOAM CELL FORMATION; KLEBSIELLA PNEUMONIAE; LIPID STORAGE; MACROPHAGE; MICROCYSTIS AERUGINOSA; MOUSE; NONHUMAN; OXIDATION KINETICS; PROTEUS VULGARIS; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS SALIVARIUS;

ANIMALS; BACTEREMIA; BACTERIA; BLOTTING, WESTERN; CELLS, CULTURED; FLOW CYTOMETRY; FOAM CELLS; HUMANS; LIPID METABOLISM; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84857594758     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.10249     Document Type: Article

References (47)

1. Rocha VZ, Libby P: Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol, 2009; 6: 399-409.
2. Steinberg D: The LDL modification hypothesis of atherogenesis: an update. J Lipid Res, 2008; 50: S376-S381.
3. Manning-Tobin JJ, Moore KJ, Seimon TA, Bell SA, Sharuk M, Alvarez-Leite JI, de Winther MP, Tabas I, Freeman MW: Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol, 2009; 29: 19-26.
4. Nicolaou G, Erridge C: Toll-like receptor-dependent lipid body formation in macrophage foam cell formation. Curr Opin Lipidol, 2010; 21: 427-433.
5. Guilherme A, Virbasius JV, Puri V, Czech MP: Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol, 2008; 9: 367-377.
6. D'Avilaa H, Maya-Monteiroa CM, Bozza PT: Lipid bodies in innate immune response to bacterial and parasite infections. Int Immunopharmacol, 2008; 8: 1308-1315.
7. Ducharme NA, Bickel PE: Lipid droplets in lipogenesis and lipolysis. Endocrinology, 2008; 149: 942-949.
8. Kitazawa T, Fukushima A, Okugawa S, Yanagimoto S, Tsukada K, Tatsuno K, Koike K, Kimura S, Kishimoto T, Shibasaki Y, Ota Y: Chlamydophilal antigens induce foam cell formation via c-Jun NH2-terminal kinase. Microbes Infect, 2007; 9: 1410-1414.
9. He P, Mei C, Cheng B, Liu W, Wang Y, Wan J: Chlamydia pneumoniae induces macrophage-derived foam cell formation by up-regulating acyl-coenzyme A: cholesterol acyltransferase 1. Microbes Infect, 2009; 11: 157-163.
10. Kalayoglu MV, Miranpuri GS, Golenbock DT, Byrne GI: Characterization of low-density lipoprotein uptake by murine macrophages exposed to Chlamydia pneumoniae. Microbes Infect, 1999; 1: 409-418.
11. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q: Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation, 2000; 102: 833-839.
12. Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, Kuhbacher T, Nikolaus S, Namsolleck P, Blaut M, Hampe J, Sahly H, Reinecke A, Haake N, Gunther R, Kruger D, Lins M, Herrmann G, Folsch UR, Simon R, Schreiber S: Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation, 2006; 113: 929-937.
13. Renko J, Lepp PW, Oksala N, Nikkari S, Nikkari ST: Bacterial signatures in atherosclerotic lesions represent human commensals and pathogens. Atherosclerosis, 2008; 201: 192-197.
14. Watt S, Aesch B, Lanotte P, Tranquart F, Quentin R: Viral and bacterial DNA in carotid atherosclerotic lesions. Eur J Clin Microbiol Infect Dis, 2003; 22: 99-105.
15. Erridge C, Burdess A, Jackson AJ, Murray C, Riggio M, Lappin D, Milligan S, Spickett CM, Webb DJ: Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma. Eur J Clin Invest, 2008; 38: 713-720.
16. Koren O, Spor A, Felin J, Fåk F, Stombaugh J, Tremaroli V, Behre CJ, Knight R, Fagerberg B, Ley RE, Bäckhed F: Microbes and Health Sackler Colloquium: Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA, 2011; 108 Suppl1: 4592-4598.
17. Kalayoglu MV, Perkins BN, Byrne GI: Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells. Microbes Infect, 2001; 3: 963-969.
18. May AE, Redecke V, Grüner S, Schmidt R, Massberg S, Miethke T, Ryba B, Prazeres da Costa C, Schömig A, Neumann FJ: Recruitment of Chlamydia pneumoniaeInfected macrophages to the carotid artery wall in noninfected, nonatherosclerotic mice. Arterioscler Thromb Vasc Biol, 2003; 23: 789-794.
19. Huang Y, Fan XG, Tang ZS, Liu L, Tian XF, Li N: Detection of Helicobacter pylori DNA in peripheral blood from patients with peptic ulcer or gastritis. APMIS, 2006; 114: 851-856.
20. Moazed TC, Kuo CC, Grayston TJ, Campbell LA: Evidence of systematic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis, 1998; 177: 1322-1325.
21. Haranaga S, Yamaguchi H, Leparc GF, Friedman H, Yamamoto Y: Detection of Chlamydia pneumoniae antigen in PBMNCs of healthy blood donors. Transfusion, 2001; 41: 1114-1119.
22. Erridge C, Stewart J, Poxton IR: Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in LPS signalling J Exp Med, 2003; 197: 1787-1791.
23. Erridge C, Kennedy S, Spickett CM, Webb DJ: Oxidised phospholipid inhibition of toll-like receptor (TLR) signalling is restricted to TLR2 and TLR4 - roles for CD14, LPS-binding protein and MD2 as targets for specificity of inhibition. J Biol Chem, 2008; 283: 24748-24759.
24. Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK: Bacteremia associated with toothbrushing and dental extraction. Circulation, 2008; 117: 3118-3125
25. Bhanji S, Williams B, Sheller B, Elwood T, Mancl L: Transient bacteremia induced by toothbrushing a comparison of the Sonicare toothbrush with a conventional toothbrush. Pediatr Dent, 2002; 24: 295-299.
26. Zierdt CH: Evidence for transient Staphylococcus epidermidis bacteremia in patients and in healthy humans. J Clin Microbiol, 1983; 17: 628-630.
27. Greenspan P, Mayer EP, Fowler SD: Nile red: a selective fluorescent stain for intracellular lipid droplets. J Cell Biol, 1985; 100: 965-973.
28. Koren E, Franzen J, Fugate RD, Alaupovic P: Analysis of cholesterol ester accumulation in macrophages by the use of digital imaging fluorescence microscopy. Atherosclerosis, 1990; 85: 175-184
29. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI: Human toll-like receptor 4 recognises host-specific LPS modifications. Nat Immunol, 2003; 3: 354-359.
30. Walton KA, Cole AL, Yeh M, Subbanagounder G, Krutzik SR, Modlin RL, Lucas RM, Nakai J, Smart EJ, Vora DK, Berliner JA: Specific phospholipid oxidation products inhibit ligand activation of Toll-like receptors 4 and 2. Arterioscler Thromb Vasc Biol, 2003; 23: 1197-1203.
31. Cao F, Castrillo A, Tontonoz P, Re F, Byrne GI: Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun, 2007; 75: 753-759.
32. D'Avila H, Melo RC, Parreira GG, Werneck-Barroso E, Castro-Faria-Neto HC, Bozza PT: Mycobacterium bovis bacillus Calmette-Guérin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J Immunol, 2006; 176: 3087-3097.
33. Mattos KA, D'Avila H, Rodrigues LS, Oliveira VG, Sarno EN, Atella GC, Pereira GM, Bozza PT, Pessolani MC: Lipid droplet formation in leprosy: Toll-like receptor-regulated organelles involved in eicosanoid formation and Mycobacterium leprae pathogenesis. J Leukoc Biol, 2010; 87: 371-384.
34. Funk JL, Feingold KR, Moser AH, Grunfeld C: Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis, 1993; 98: 67-82.
35. Ye Q, Chen Y, Lei H, Liu Q, Moorhead JF, Varghese Z, Ruan XZ: Inflammatory stress increases unmodified LDL uptake via LDL receptor: an alternative pathway for macrophage foam-cell formation. Inflamm Res, 2009; 58: 809-818.
36. Kalayoglu MV, Byrne GI: Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis, 1998; 177: 725-729.
37. Maitra U, Parks JS, Li L. An innate immunity signaling process suppresses macrophage ABCA1 expression through IRAK-1-mediated downregulation of retinoic acid receptor alpha and NFATc2. Mol Cell Biol, 2009; 29: 5989-5997.
38. Castrillo A, Joseph SB, Vaidya SA, Haberland M, Fogelman AM, Cheng G, Tontonoz P: Crosstalk between LXR and Toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell, 2003; 12: 805-816.
39. Michelson KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M: Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA, 2004; 101: 10679-10684.
40. Mullick AE, Tobias PS, Curtiss LK: Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest, 2005; 115: 3149-3156.
41. Madan M, Amar S: Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings. PLoS ONE, 2008; 3: e3204.
42. Hayashi C, Madrigal AG, Liu X, Ukai T, Goswami S, Gudino CV, Gibson FC 3rd, Genco CA: Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses. J Innate Immun, 2010; 2: 334-343.
43. Mullick AE, Soldau K, Kiosses WB, Bell TA 3rd, Tobias PS, Curtiss LK: Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med, 2008; 205: 373-383.
44. Higashimori M, Tatro JB, Moore KJ, Mendelsohn ME, Galper JB, Beasley D: Role of Toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol, 2011; 31: 50-57.
45. Ball RY, Stowers EC, Burton JH, Cary NR, Skepper JN, Mitchinson MJ: Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis, 1995; 114: 45-54.
46. Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E: Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res, 2009; 50: 90-97.
47. Erridge C: The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4. Br J Nutr, 2010; 20: 1-9.